The recommended dose of Humira for patients with polyarticular juvenile idiopathic arthritis, aged 13 years and above, is 40 mg adalimumab administered every other week as a single dose via subcutaneous injection.
Soovitatav Humira annus polüartikulaarse juveniilse reumatoidartriidiga patsientidele, vanuses 13 ja enam eluaastat, on 40 mg adalimumabi, manustatuna ühekordse annusena igal teisel nädalal nahaaluse süstena.